异基因移植后急性移植物抗宿主病患者骨髓内皮祖细胞受损
这项前瞻性病例对照研究发现,与无急性移植物抗宿主病(aGVHD)的患者相比,aGVHD患者骨髓内皮祖细胞(EPC)数量减少且功能失调,表现为迁移和血管生成能力下降、活性氧(ROS)水平和凋亡增加。aGVHD严重程度及GVHD相关血细胞减少与骨髓EPC受损相关,且EPC受损与ROS水平正相关。结果提示骨髓EPC减少和功能失调可能参与aGVHD发病机制,改善骨髓EPC可能是aGVHD患者的潜在治疗途径,但需进一步验证。
要点
- aGVHD患者骨髓EPC数量减少且功能失调,迁移和血管生成能力下降。
- aGVHD患者骨髓EPC的ROS水平和凋亡增加,且EPC受损与ROS水平正相关。
- aGVHD严重程度及GVHD相关血细胞减少与骨髓EPC受损相关。
核心结论
- 结果提示骨髓EPC减少和功能失调可能参与aGVHD的发病机制。
- 数据表明改善骨髓EPC可能是aGVHD患者有前景的治疗途径,但这些发现需进一步验证。
研究设计与样本
- 前瞻性病例对照研究,比较aGVHD患者与无aGVHD患者的骨髓EPC及骨髓CD34+细胞。
主要发现
- 与无aGVHD患者相比,aGVHD患者骨髓EPC减少且功能失调,表现为迁移和血管生成能力下降、ROS水平和凋亡增加。
- 与无aGVHD患者相比,aGVHD患者骨髓CD34+细胞频率降低,ROS水平、凋亡和DNA损伤增加,集落形成单位铺板效率降低。
- aGVHD严重程度及GVHD相关血细胞减少与aGVHD患者骨髓EPC受损相关。
- EPC受损与ROS水平正相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出这些发现需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Graft-versus-host disease (GVHD) is a major complication after allogeneic haematopoietic stem cell transplantation (allo-HSCT) that is frequently associated with bone marrow (BM) suppression, and clinical management is challenging. BM endothelial progenitor cells (EPCs) play crucial roles in the regulation of haematopoiesis and thrombopoiesis. However, little is known regarding the functional roles of BM EPCs in acute GVHD (aGVHD) patients. In the current prospective case-control study, reduced and dysfunctional BM EPCs, characterized by decreased migration and angiogenesis capacities and increased levels of reactive oxygen species (ROS) and apoptosis, were found in aGVHD patients compared with those without aGVHD. Moreover, lower frequency and increased levels of ROS, apoptosis and DNA damage, but reduced colony-forming unit-plating efficiency were found in BM CD34+ cells of aGVHD patients compared with those without aGVHD. The severity of aGVHD and GVHD-mediated cytopenia was associated with BM EPC impairment in aGVHD patients. In addition, the EPC impairment positively correlated with ROS level. Taken together, our results suggest that reduced and dysfunctional BM EPCs may be involved in the pathogenesis of aGVHD. Although these findings require validation, our data indicate that improvement of BM EPCs may represent a promising therapeutic approach for aGVHD patients.
引用
- Cao XN, Kong Y, Song Y, et al. Impairment of bone marrow endothelial progenitor cells in acute graft-versus-host disease patients after allotransplant. Br J Haematol. 2018. PMID: 29984829. doi:10.1111/bjh.15456
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。